[TJ13]

Monoclonal antibodies for multiple myeloma

by TJ13 on Tue Aug 05, 2014 11:22 pm

I have just been reading some on the research with monoclonal antibodies in multiple myeloma.

Does anyone know more about these, or has anyone had these used with their myeloma?

It seems like such a better idea than all these toxic chemos and their side effects.

[Beacon Staff]

Re: Monoclonal antibodies for multiple myeloma

by Beacon Staff on Tue Aug 05, 2014 11:44 pm

Just so everyone has an easy reference, the potential new myeloma therapies that fall into the category of "monoclonal antibodies" include elotuzumab, daratumumab, SAR650984, MOR202, IPH-2101, and (loosely) the antibody-chemo drug conjugate BT-062 (indatuximab ravtansine).

In addition, the monoclonal antibody Sylvant (siltuximab) also has been tested as a potential myeloma therapy. It has been approved by the FDA as a treatment for Castleman's disease, but generally is not expected to see widespread use as a myeloma therapy.

(All links above go to lists of Beacon news stories with information on each specific drug.)